Saturday, 5 September 2026European Markets

VÅR ENERGI And DNO Have A High Dividend Yield And Return On Equity In The Oil & Gas E&P Industry.

Loading stream...

(VIANEWS) - VÅR ENERGI (VAR.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Oil & Gas E&P industry.

Financial Asset Price Forward Dividend Yield Return on Equity
VÅR ENERGI (VAR.OL) kr35.76 12.97% 37.56%
DNO (DNO.OL) kr10.31 9.94% 19.33%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. VÅR ENERGI (VAR.OL)

12.97% Forward Dividend Yield and 37.56% Return On Equity

Vår Energi AS operates as an independent upstream oil and gas company on the Norwegian continental shelf in Norway. It produces crude oil, liquified natural gas, and natural gas liquids. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was incorporated in 1965 and is headquartered in Sandnes, Norway. Vår Energi AS operates as a subsidiary of Eni International B.V.

Earnings Per Share

As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr2.23.

PE Ratio

VÅR ENERGI has a trailing twelve months price to earnings ratio of 16.04. Meaning, the purchaser of the share is investing kr16.04 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 37.56%.

Sales Growth

VÅR ENERGI's sales growth is negative 2.6% for the present quarter and 32.1% for the next.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is 19.8% and 159.1%, respectively.

More news about VÅR ENERGI.

2. DNO (DNO.OL)

9.94% Forward Dividend Yield and 19.33% Return On Equity

DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. The company holds 75% operating interests in the Tawke and Peshkabir fields, and 64% operating interests in the e Baeshiqa license located in the Kurdistan region of Iraq; has production licenses across 10 fields Norway and two fields in the United Kingdom; and operating interests in the producing Block CI-27, as well as operates the exploration Block CI-12 in West Africa. DNO ASA was founded in 1971 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, DNO has a trailing twelve months EPS of kr0.22.

PE Ratio

DNO has a trailing twelve months price to earnings ratio of 46.86. Meaning, the purchaser of the share is investing kr46.86 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.33%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is a negative 65.6% and a negative 86.7%, respectively.

More news about DNO.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com